Portfolio update - 2022 January 3

My top (>2%) positions in no particular order: BRKB, FB, GOOG, PSHZF, AAPL,
In:
Out:

Fixed income: 6%
Cash: 6%

Sectors (kinda): Insurance (BRK): 12%, Malone/media: 0%, Banks/financials: 6%, Stock funds: 11%, Industrial: 0%, Consumer: 1%, Medical/pharma: 1%, Tech: 39%, Various owner-operators (not included in other categories): 4%

New positions: ZEN, TER, ATY, ACHR, BMBL, ZIP, KD, IBM, DOCU
Positions increased: FB, KARO, GOOG, STNE, PINS, PLTK, V, IAC, POSH, PAGS, ZM, FICO, VMW, TWTR, CPNG, XBI, AMZN, VEEV, COIN
Positions reduced: ETSY, RDBBY, CURN, JPM, EXPE
Positions eliminated: ANGI, HMLPRA, MNTV, DIS, MGI, DISCK, VIAC, BKNG, NTES, EXXRF, KKR, WLDBF, LBRDA, EEFT, NTDOY, CBOE, FSPHX, IWO, MITK, IDXX, PWFL, ROP, SABR, QLYS, PETQ, BOX
Flip-flop: ATUS (sold), NWINF (kept), PSFE (sold), ANCTF (sold)

2021 IRR ~15.76%. The "growth" account that smashed 2020 had 2021 IRR of ~1.2%

Lessons from 2021:
- Buying/hodling growth at any price does not work (that's the account with 1.2% return in 2021 )
- Holding cash/cash equivalent SPACs in bull market does not work ( -3% in the account that held mostly SPACs/PSTH + some other stuff )
- AAPL/BRK/GOOGL/FB still worked, so KISS would have worked ( 28% return in account that had majority of money in these companies ).

Somewhat unexpected returns: subpar AMZN, ADSK, LBRDA (sold), MA, V.

BRK beat the index (for a change).

Other positive contributions: BAM, CNSWF, COST (large runup, tiny position), DFS (sold), DPZ (large runup, tiny position, sold), INTU, JPM (sold), MCO, NVDA, OTCM (large runup), TOITF, TRRSF.

International indexes still underperformed hugely - is this the longest international underperformance ever? Similar to value-vs-growth underperformance.

PSHZF midteens performance - somewhat expected - still hodling.

Too many stocks -50% (that's minus 50%) to mention.

My 401(k) which is 40% US indexes, 40% international, 20% bonds returned 16%. So pretty much the same as my active portfolio, but way worse than SP500 since international and bonds/cash underperformed hugely.

Did a large portfolio cleanup at year-end/new-year. Still work in progress. There will be a lot more changes.

Buys: almost everything is a value/valuation add. There's one company that's a tracking position. Can anyone spot it?

Sells: a mix of valuation, low conviction, and too-much-effort-to-keep-track sales. Almost all stocks sold might do well. Might be interesting to track their performance and compare to index or to my remaining portfolio.